Cited by 160Cancer, Hypoxia, and MetabolismPancreatic and Hepatic Oncology ResearchMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function

Open access

Rajeshkumar, N.V., Dutta, Prasanta, Yabuuchi, Shinichi, de Wilde, Roeland F., Martinez, Gary V., Le, Anne, Kamphorst, Jurre J., Rabinowitz, Joshua D., Jain, Sanjay K., Hidalgo, Manuel, Dang, Chi V., Gillies, Robert J., Maitra, Anirban·2015·Cancer Research

DOI 10.1158/0008-5472.can-15-0108PMC PMC4537812

Published version of a preprint

Open this paper in CoChat — free account

Abstract

The “Warburg effect” describes a peculiar metabolic feature of many solid tumors, namely their increased glucose uptake and high glycolytic rates, which allow cancer cells to accumulate building blocks for the biosynthesis of macromolecules. During aerobic glycolysis, pyruvate is preferentially metabolized to lactate by the enzyme lactate dehydrogenase-A (LDH-A), suggesting a possible vulnerability at this target for small-molecule inhibition in cancer cells. In this study, we used FX11, a small-molecule inhibitor of LDH-A, to investigate this possible vulnerability in a panel of 15 patient-derived mouse xenograft (PDX) models of pancreatic cancer. Unexpectedly, the p53 status of the PDX tumor determined the response to FX11. Tumors harboring wild-type (WT) TP53 were resistant to FX11. In contrast, tumors harboring mutant TP53 exhibited increased apoptosis, reduced proliferation indices, and attenuated tumor growth when exposed to FX11. [18F]-FDG PET-CT scans revealed a relative increase in glucose uptake in mutant TP53 versus WT TP53 tumors, with FX11 administration downregulating metabolic activity only in mutant TP53 tumors. Through a noninvasive quantitative assessment of lactate production, as determined by 13C magnetic resonance spectroscopy (MRS) of hyperpolarized pyruvate, we confirmed that FX11 administration inhibited pyruvate-to-lactate conversion only in mutant TP53 tumors, a feature associated with reduced expression of the TP53 target gene TIGAR, which is known to regulate glycolysis. Taken together, our findings highlight p53 status in pancreatic cancer as a biomarker to predict sensitivity to LDH-A inhibition, with regard to both real-time noninvasive imaging by 13C MRS as well as therapeutic response. Cancer Res; 75(16); 3355–64. ©2015 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-0108

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528
Self-citation
The Role of Autophagy in Cancer: Therapeutic Implications
Yang, Z. J., Chee, C. E., Huang, S., & Sinicrope, F. A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0047 · Cited by 1,243

Show all 48 references

Sorted by citations

Pancreatic cancer: Advances and challenges
Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321
Self-citation
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
Self-citation
Genetics and biology of pancreatic ductal adenocarcinoma
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes & Development · doi:10.1101/gad.275776.115 · Cited by 527
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
Kurhanewicz, J. V., Vigneron, D. B., Ardenkjær‐Larsen, J. H., Bankson, J. A., Brindle, K. M., Cunningham, C. H., Gallagher, F. A., Keshari, K. R., Kjær, A., Laustsen, C., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.09.006 · Cited by 441
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin, C., Yang, G., Yang, J., Ren, B., Wang, H., Chen, G., Zhao, F., You, L., Wang, W., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01169-7 · Cited by 433
Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Halbrook, C. J., & Lyssiotis, C. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.006 · Cited by 403
The enhancement of glycolysis regulates pancreatic cancer metastasis
Yang, J., Ren, B., Yang, G., Wang, H., Chen, G., You, L., Zhang, T., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03278-z · Cited by 347
Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells
Yao, X., Li, W., Fang, D., Xiao, C., Wu, X. W., Li, M., & Luo, Z. Y. (2021) · Advanced Science · doi:10.1002/advs.202100997 · Cited by 292
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Elgogary, A., Xu, Q., Poore, B., Alt, J., Zimmermann, S. C., Zhao, L., Fu, J., Chen, B., Xia, S., Liu, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611406113 · Cited by 234
Self-citation
Hypoxia and acidosis: immune suppressors and therapeutic targets
Damgaci, S., Ibrahim‐Hashim, A., Enríquez‐Navas, P. M., Pilon‐Thomas, S., Güveniş, A., & Gillies, R. J. (2018) · Immunology · doi:10.1111/imm.12917 · Cited by 231
Self-citation
Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Bose, S., Zhang, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_1 · Cited by 240
Self-citation
Role of long non-coding RNAs in glucose metabolism in cancer
Fan, C., Tang, Y., Wang, J., Xiong, F., Guo, C. J., Wang, Y., Zhang, S., Gong, Z., Wei, F., Yang, L., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0699-3 · Cited by 182
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts
Bhagat, T. D., Ahrens, D. V., Dawlaty, M. M., Zou, Y., Baddour, J., Achreja, A., Zhao, H., Yang, L., Patel, B., Kwak, C., et al. (2019) · eLife · doi:10.7554/elife.50663 · Cited by 178
Self-citation
Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives
Gu, X.-Y., Yang, J., Lai, R., Zhou, Z., Tang, D., Hu, L., & Zhao, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563303 · Cited by 174
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 159
NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
Gu, Z., Xia, J., Xu, H., Frech, I., Tricot, G. J. K., & Zhan, F. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0392-4 · Cited by 148
Barriers and opportunities for gemcitabine in pancreatic cancer therapy
Beutel, A. K., & Halbrook, C. J. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2022 · Cited by 150
Glycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 135
The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
Yu, L., Chen, X., Wang, L., & Chen, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7676 · Cited by 129
Glucose Metabolism in Pancreatic Cancer
Liang, Y., Raj, P. S., Yao, W., & Ying, H. (2019) · Cancers · doi:10.3390/cancers11101460 · Cited by 128
Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer
Kitamura, F., Semba, T., Yasuda-Yoshihara, N., Yamada, K., Nishimura, A., Yamasaki, J., Nagano, O., Yasuda, T., Yonemura, A., Tong, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163022 · Cited by 121
“138 Similarly, pharmacological inhibition of LDHA with FX11, a selective LDHA 139 inhibitor(16, 17), significantly decreased the peak ECAR (Figure 1F) and lactate 140 production (Figure 1G) after oligomycin treatment in both PDAC cell lines.”
Background
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies
Hassouni, B. E., Granchi, C., Vallés‐Martí, A., Supadmanaba, I. G. P., Bononi, G., Tuccinardi, T., Funel, N., Jiménez, C. R., Peters, G. J., Giovannetti, E., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.025 · Cited by 113
Pancreatic cancer: Current research and future directions
Falasca, M., Kim, M., & Casari, I. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.001 · Cited by 101
LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
Hou, X., Shi, X., Zhang, W., Li, D., Hu, L., Yang, J., Zhao, J., Wei, S., Wei, X., Ruan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03641-8 · Cited by 101
Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Oliveira, E. D., Kamphorst, J. J., Rabinowitz, J. D., Tejero, H., Al‐Shahrour, F., Hidalgo, M. M., Maitra, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1115 · Cited by 89
Self-citation
Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome
Mohammad, G. H., Damink, S. W. M. O., Malagó, M., Dhar, D. K., & Pereira, S. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151635 · Cited by 93
RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing
Yan, Q., Zeng, P., Zhou, X., Zhao, X., Chen, R., Qiao, J., Ling, F., Zhu, Z., Zhang, G., & Chen, C. (2021) · Oncogene · doi:10.1038/s41388-021-01666-z · Cited by 86
LDHA is a direct target of miR‐30d‐5p and contributes to aggressive progression of gallbladder carcinoma
He, Y., Chen, X., Yu, Y. H., Li, J., Hu, Q., Xue, C., Chen, J., Shen, S., Luo, Y., Ren, F., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22799 · Cited by 82
LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis
Dorneburg, C., Fischer, M., Barth, T. F. E., Mueller‐Klieser, W., Hero, B., Gecht, J., Carter, D. R., Preter, K. D., Mayer, B., Christner, L., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2578 · Cited by 81
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Shah, D. D., Chorawala, M. R., Raghani, N. R., Patel, R., Fareed, M., Kashid, V. A., & Prajapati, B. G. (2025) · Medical Oncology · doi:10.1007/s12032-025-02641-4 · Cited by 86
Exploiting pancreatic cancer metabolism: challenges and opportunities
Santis, M. C. D., Bockorny, B., Hirsch, E., Cappello, P., & Martini, M. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.03.008 · Cited by 85
Macrophages in pancreatic cancer: An immunometabolic perspective
Yang, J. M., Li, Y., Sun, Z., & Zhan, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.029 · Cited by 72
Cryptosporidium Lactate Dehydrogenase Is Associated with the Parasitophorous Vacuole Membrane and Is a Potential Target for Developing Therapeutics
Zhang, H., Guo, F., & Zhu, G. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005250 · Cited by 69
Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy
Kozal, K., Jóźwiak, P., & Krześlak, A. (2021) · Cancer Control · doi:10.1177/10732748211041243 · Cited by 65
Glucose metabolic phenotype of pancreatic cancer
Chan, A. K. C., Bruce, J. I. E., & Siriwardena, A. K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i12.3471 · Cited by 62
An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma
Wen, C., Huang, K., Jiang, L.-L., Lu, X., Dai, Y., Shi, M.-M., Tang, X.-M., Wang, Q., Zhang, X., Wang, P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914557116 · Cited by 61
The Network Zoo: a multilingual package for the inference and analysis of gene regulatory networks
Guebila, M. B., Wang, T., Lopes‐Ramos, C. M., Fanfani, V., Weighill, D., Burkholz, R., Schlauch, D., Paulson, J. N., Altenbuchinger, M., Shutta, K. H., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02877-1 · Cited by 55
Homeodomain‐interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer
Qin, Y., Hu, Q., Ji, S., Xu, J., Dai, W., Liu, W., Xu, W., Sun, Q., Zhang, Z., Ni, Q., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12603 · Cited by 54
The Heterogeneity of Liver Cancer Metabolism
Salazar, J., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_9 · Cited by 57
Self-citation
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Tong, Z., Hou, S., Bateman, S., Pierce, D. W., Heise, C. C., Hoff, D. D. V., Maitra, A., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.215 · Cited by 51
Self-citation
Diisopropylethylamine/hexafluoroisopropanol‐mediated ion‐pairing ultra‐high‐performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism
Guo, L., Worth, A. J., Mesaros, C., Snyder, N. W., Glickson, J. D., & Blair, I. A. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7667 · Cited by 51
The metabolic landscape of cancer stem cells
Dando, I., Pozza, E. D., Biondani, G., Cordani, M., Palmieri, M., & Donadelli, M. (2015) · IUBMB Life · doi:10.1002/iub.1426 · Cited by 50
Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect
Scroggins, B. T., Matsuo, M., White, A. O., Saito, K., Munasinghe, J., Sourbier, C., Yamamoto, K., Diaz, V., Takakusagi, Y., Ichikawa, K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1957 · Cited by 49
Glycolysis in the progression of pancreatic cancer.
Chang, X., Liu, X., Wang, H., Yang, X., & Gu, Y. (2022) · PubMed Central · Cited by 49
p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer
Chang, H. W., Kim, M. R., Lee, H. J., Lee, H. M., Kim, G. C., Lee, Y. S., Nam, H. Y., Lee, M., Jang, H. J., Lee, K. E., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0697-6 · Cited by 48
Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
Huang, H., Li, S., Tang, Q., & Zhu, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.680955 · Cited by 49
Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis
Tan, J., You, Y., Guo, F., Xu, J., Dai, H., & Bie, P. (2017) · Oncology Letters · doi:10.3892/ol.2017.5586 · Cited by 48
Glycerol-3-phosphate phosphatase/PGP: Role in intermediary metabolism and target for cardiometabolic diseases
Possik, E., Madiraju, S. R. M., & Prentki, M. (2017) · Biochimie · doi:10.1016/j.biochi.2017.08.001 · Cited by 46
Hyperpolarized Carbon 13 MRI: Clinical Applications and Future Directions in Oncology
Deen, S. S., Rooney, C. H. E., Shinozaki, A., McGing, J., Grist, J. T., Tyler, D. J., Serrão, E. M., & Gallagher, F. A. (2023) · Radiology Imaging Cancer · doi:10.1148/rycan.230005 · Cited by 46
Research into cancer metabolomics: Towards a clinical metamorphosis
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45
The diverse role of TIGAR in cellular homeostasis and cancer
Geng, J., Yuan, X., Wei, M., Wu, J., & Qin, Z. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1489133 · Cited by 45
Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells
Deus, C. M., Serafim, T. L., Novais, S. M., Vilaça, A., Moreira, A. C., Sardão, V. A., Cardoso, S. M., & Oliveira, P. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1784-x · Cited by 43
Pancreatic Cancer: “A Riddle Wrapped in a Mystery inside an Enigma”
Borazanci, E. H., Dang, C. V., Robey, R. W., Bates, S. E., Chabot, J. A., & Hoff, D. D. V. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2070 · Cited by 42
Self-citation
Imaging Cancer Metabolism
Momcilovic, M., & Shackelford, D. B. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.220 · Cited by 42
The Intratumoral Heterogeneity of Cancer Metabolism
Nabi, K., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_10 · Cited by 42
Self-citation
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 43
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 39
The biological role of metabolic reprogramming in pancreatic cancer
Suzuki, T., Otsuka, M., Seimiya, T., Iwata, T., Kishikawa, T., & Koike, K. (2020) · MedComm · doi:10.1002/mco2.37 · Cited by 38
Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets
Andersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 40
Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling
Liu, R., Ma, Y., Hu, X., Ren, W., Liao, Y., Wang, H., Zhu, J., Wu, K., He, B., & Sun, W. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4527 · Cited by 38
Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer
Dutta, P., Perez, M. V. R., Lee, J.-H., Kang, Y., Pratt, M. F., Salzillo, T. C., Weygand, J., Zacharias, N. M., Gammon, S. T., Koay, E. J., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00132 · Cited by 38
Self-citation
The mitochondrial regulation in ferroptosis signaling pathway and its potential strategies for cancer
Sun, K., Zhi, Y., Ren, W., Li, S., Zhou, X., Gao, L., & Zhi, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115892 · Cited by 37
Role of multifaceted regulators in cancer glucose metabolism and their clinical significance
Zhao, L., Mao, Y., Zhao, Y., Cao, Y., & Chen, X. (2016) · Oncotarget · doi:10.18632/oncotarget.7765 · Cited by 37
Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions
Pinho, A. V., Mawson, A., Gill, A. J., Arshi, M., Warmerdam, M., Giry-Laterrière, M., Eling, N., Lie, T., Kuster, E., Camargo, S. M. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11013 · Cited by 37
Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
Schofield, H. K., Zeller, J., Espinoza, C. E., Halbrook, C. J., Vecchio, A. D., Magnuson, B., Fabo, T., Daylan, A. E. C., Kovalenko, I., Lee, H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97422 · Cited by 38
Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
Rai, V., & Agrawal, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228502 · Cited by 36
The Intratumoral Heterogeneity of Cancer Metabolism
Nabi, K., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_11 · Cited by 37
Self-citation
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer
Rice, M. A., Kumar, V., Tailor, D., Garcia-Marques, F. J., Hsu, E., Liu, S., Bermudez, A., Vijayalakshmi, K., Shankar, V., Inde, Z., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100502 · Cited by 34
Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency
Zhao, X., Zhou, T.-R., Wang, Y., Bao, M., Ni, C., Ding, L., Sun, S., Dong, H., Li, J., & Liang, C. (2023) · Cancer Science · doi:10.1111/cas.15763 · Cited by 34
Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis
Cheng, L., Qin, T., Ma, J., Duan, W., Xu, Q., Li, X., Han, L., Li, W., Wang, Z., Zhang, D., et al. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190626120359 · Cited by 32
18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
Guan, J., Xiao, N., Chen, M., Zhou, W. L., Zhang, Y. W., Wang, S., Dai, Y. M., Li, L., Zhang, Y., Li, Q. Y., et al. (2016) · Medicine · doi:10.1097/md.0000000000004421 · Cited by 30
The Heterogeneity of Breast Cancer Metabolism
Tan, J., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_6 · Cited by 36
Self-citation
The potential roles of p53 signaling reactivation in pancreatic cancer therapy
Ou, A., Zhao, X., & Lu, Z. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188662 · Cited by 30
Ribosomal protein S3 selectively affects colon cancer growth by modulating the levels of p53 and lactate dehydrogenase
Alam, E., Maaliki, L., & Nasr, Z. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05683-1 · Cited by 29
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
Curcio, C., Brugiapaglia, S., Bulfamante, S., Follia, L., Cappello, P., & Novelli, F. (2021) · Molecules · doi:10.3390/molecules26061642 · Cited by 28
Pancreatic cancer from bench to bedside: molecular pathways and treatment options
Kosmidis, C. S., Sapalidis, K. G., Kotidis, E. V., Mixalopoulos, N., Zarogoulidis, P., Tsavlis, D., Baka, S., Man, Y.-G., & Kanellos, J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.05.11 · Cited by 26
FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity
Gopinath, K., Kaiser, P., Abed, U. A., Weiner, J. M., Moura‐Alves, P., Brinkmann, V., & Kaufmann, S. H. E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.041954 · Cited by 25
New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
Capula, M., Mantini, G., Funel, N., & Giovannetti, E. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1693256 · Cited by 27
Discovery of novel human lactate dehydrogenase inhibitors: Structure-based virtual screening studies and biological assessment
Magno, L. D., Coluccia, A., Bufano, M., Ripa, S., Regina, G. L., Nalli, M., Pastena, F. D., Canettieri, G., Silvestri, R., & Frati, L. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114605 · Cited by 25
The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response
Guo, X., Song, J., Liu, M., Ou, X., & Guo, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2356831 · Cited by 24
Lactate-Mediated Crosstalk Between Tumor Cells and Cancer-Associated Fibroblasts: Mechanisms and Therapeutic Opportunities
Tan, S., Zhou, F., & Wu, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125583 · Cited by 29
Hyperpolarized 13C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma
Gordon, J. W., Chen, H., Nickles, T. M., Lee, P. M., Bok, R., Ohliger, M. A., Okamoto, K., Ko, A. H., Larson, P. E. Z., & Wang, Z. J. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29162 · Cited by 22
Evaluation of 18F-FDG PET/CT parameters for reflection of aggressiveness and prediction of prognosis in early-stage cervical cancer
Zhang, L., Sun, H., Du, S., Xu, W., Xin, J., & Guo, Q. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000909 · Cited by 22
Intrathecal lactate dehydrogenase A inhibitors FX11 and oxamate alleviate chronic constriction injury-induced nociceptive sensitization through neuroinflammation and angiogenesis
Cheng, H., Chen, N., Chen, W.-F., Wu, Z., Sun, Y., Teng, W.-N., Su, F.-W., Sung, C., & Wen, Z. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01916-x · Cited by 22
Metabolic Constrains Rule Metastasis Progression
Roda, N., Gambino, V., & Giorgio, M. (2020) · Cells · doi:10.3390/cells9092081 · Cited by 22
Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells
Das, B., & Senapati, S. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1272-2 · Cited by 21
Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging
Dutta, P., Salzillo, T. C., Pudakalakatti, S., Gammon, S. T., Kaipparettu, B. A., McAllister, F. M., Wagner, S. R., Frigo, D. E., Logothetis, C. J., Zacharias, N. M., et al. (2019) · Cells · doi:10.3390/cells8040340 · Cited by 20
Self-citation
Achyranthes bidentata extract protects chondrocytes functions through suppressing glycolysis and apoptosis via MAPK/AKT signaling axis.
Ma, D., Li, Y., Xiao, W. L., Peng, L., Wang, L., Liao, Z., & Hu, L. (2020) · PubMed Central · Cited by 19
Retracted
Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy
Dutta, P., Castro-Pando, S., Mascaró, M., Riquelme, E. M., Zoltan, M. A., Zacharias, N. M., Gammon, S. T., Piwnica-Worms, D. R., Pagel, M. D., Sen, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103722 · Cited by 19
Self-citation
The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy
Cruz‐Bermúdez, A., Briviesca, R. L., Casarrubios, M., Sierra‐Rodero, B., & Provencio, M. (2021) · Biomedicines · doi:10.3390/biomedicines9040361 · Cited by 20
Glycometabolic rearrangements–aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential
Zhang, Z., & Zhang, H. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2015321 · Cited by 18
New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
Mireștean, C. C., Iancu, R. I., & Iancu, D. P. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.908695 · Cited by 18
Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression
Saeed, T., Ahmad, J., Kanwal, S., Holowatyj, A. N., Sheikh, I. A., Paracha, R. Z., Shafi, A., Siddiqa, A., Bibi, Z., Khan, M., et al. (2016) · PeerJ · doi:10.7717/peerj.2348 · Cited by 19
The Intricate Metabolism of Pancreatic Cancers
Camelo, F., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_5 · Cited by 19
Self-citation
Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer
Enriquez, J. S., Chu, Y., Pudakalakatti, S., Hsieh, K., Salmon, D., Dutta, P., Zacharias, N. M., Lurie, E., Millward, S. W., McAllister, F. M., et al. (2021) · JMIR Medical Informatics · doi:10.2196/26601 · Cited by 19
Self-citation
Cancer Stem Cell Metabolism
Alvina, F. B., Gouw, A. M., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_12 · Cited by 17
Self-citation
Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care
Ouyang, H., Ma, W., Liu, F., Yue, Z., Fang, M., Quan, M., & Pan, Z. (2017) · Pancreatology · doi:10.1016/j.pan.2017.07.002 · Cited by 16
Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer
Liu, M., Liu, W., Qin, Y., Xu, X., Yu, X., Zhuo, Q., & Ji, S. (2020) · Experimental Hematology and Oncology · doi:10.1186/s40164-020-00179-x · Cited by 17
Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas
Zheng, G.-L., Zhang, G.-J., Zhao, Y., & Zheng, Z.-C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901182 · Cited by 15
SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma
Liu, E., Zhang, Z., Cheng, X., Liu, X., & Cheng, L. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0681-6 · Cited by 15

Authors: Rajeshkumar, N. V., Dutta, P., Yabuuchi, S., de Wilde, R. F., Martinez, G. V., Le, A., Kamphorst, J. J., Rabinowitz, J. D., Jain, S. K., Hidalgo, M., Dang, C. V., Gillies, R. J., & Maitra, A.
Affiliations: Johns Hopkins University (US)
Moffitt Cancer Center (US)
1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Princeton University (US)
Spanish National Cancer Research Centre (ES)
Abramson Cancer Center (US)
The University of Texas MD Anderson Cancer Center (US)
Corresponding author: Maitra, Anirban
ORCID: Dutta, Prasanta
Martinez, Gary V.
Le, Anne
Kamphorst, Jurre J.
Rabinowitz, Joshua D.
Jain, Sanjay K.
Hidalgo, Manuel
Dang, Chi V.
Gillies, Robert J.
Maitra, Anirban
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2015-08-13
Volume: 75
Issue: 16
Pages: 3355-3364
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-15-0108
PMC: PMC4537812
OpenAlex: W2164355096
Cited by: 158
References: 48
Citations by year: 2026: 5 · 2025: 10 · 2024: 12 · 2023: 12 · 2022: 14 · 2021: 29 · 2020: 16 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 15 · 2015: 4
FWCI: 5.07
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Cancer Research UK (22311)
National Cancer Institute (R01CA113669, R01CA057341, R01CA077575, R01CA051497, R01CA163591, P30CA016520)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Warburg effect, pancreatic cancer, p53 status, TP53 mutation, aerobic glycolysis, lactic acid production, TIGAR, glucose metabolism, patient-derived xenografts, predictive biomarkers, 13C NMR, hyperpolarized pyruvate, 18F-FDG PET/CT
MeSH terms: Lactate Dehydrogenase 5, Animals, Glycolysis, Humans, Immunohistochemistry, Isoenzymes, L-Lactate Dehydrogenase, Lactates, Male, Mice, Nude, Mutation, Naphthalenes, Pancreatic Neoplasms, Phosphoric Monoester Hydrolases, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Apoptosis, Pyruvic Acid, Fluorodeoxyglucose F18, Reverse Transcriptase Polymerase Chain Reaction, Xenograft Model Antitumor Assays, Tumor Burden, Intracellular Signaling Peptides and Proteins, Cell Proliferation, Positron-Emission Tomography, Apoptosis Regulatory Proteins, Carbon-13 Magnetic Resonance Spectroscopy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks